GlassScriptPhysician profile
Michael Allen Boxer
NPI 1275502544
$30,034.17
in general payments reported to CMS, 2019-2025
47 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $2,903 · 2021: $5,105 · 2022: $15.28.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $9,252.35 | 2019 | |
| Abbvie INC. | $5,848.66 | 2019 | |
| Genzyme Corporation | $3,093.65 | 2019-2021 | |
| Adaptive Biotechnologies Corporation | $2,095.08 | 2019 | |
| F. Hoffmann-La Roche Ag | $2,052.05 | 2019-2020 | |
| Karyopharm Therapeutics INC. | $1,584.66 | 2020-2021 | |
| Beigene USA, INC. | $1,350.00 | 2020 | |
| Beigene, LTD. | $975.00 | 2020-2021 | |
| Pharmacosmos Therapeutics INC. | $666.64 | 2020-2021 | |
| Amgen INC. | $327.42 | 2019 | |
| Genentech USA, INC. | $277.96 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $261.71 | 2019-2020 | |
| Pfizer INC. | $223.87 | 2019-2020 | |
| Janssen Biotech, INC. | $217.74 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $202.93 | 2019 |
Show all 43 companies
4 companies reported research payments only; those appear in the research section below.
Research and ownership
$6,240.93 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Boxer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.